How Has the Infectious Disease Therapeutics Market Size Evolved in Recent Years?
The infectious disease therapeutics market has seen considerable growth due to a variety of factors.
• The infectious disease therapeutics market has expanded significantly in recent years. It will grow from $141.08 billion in 2024 to $151.04 billion in 2025, at a CAGR of 7.1%.
This growth is driven by the increasing prevalence of infectious diseases, the rising incidence of viral diseases, awareness about diagnostic tools, demand for quick and efficient diagnostic testing, and the growing importance of antimicrobial stewardship.
What Is The Forecast For The Infectious Disease Therapeutics Market Size?
The infectious disease therapeutics market is expected to maintain its strong growth trajectory in upcoming years.
• The infectious disease therapeutics market is expected to grow to $196.5 billion by 2029 at a CAGR of 6.8%.
Growth is fueled by increased investments, clinical trial expansion, a focus on disease prevention, early diagnosis awareness, and funding. Trends include partnerships, product approvals, and R&D in therapeutics.
What Are The Essential Drivers Behind The Growth Of The Infectious Disease Therapeutics Market?
The growing prevalence of infectious diseases is expected to boost the infectious disease therapeutics market. The rise in infectious diseases is driven by factors like climate change, antimicrobial resistance, and ecological disruptions. Infectious disease therapeutics are essential for treating infections and controlling their spread. According to the Centers for Disease Control and Prevention, U.S. tuberculosis cases increased by 5.9% in 2022 compared to the previous year. Therefore, the rising prevalence of infectious diseases is fueling the growth of the infectious disease therapeutics market.
How Is The Global Infectious Disease Therapeutics Market Divided Into Key Segments?
The infectious disease therapeutics market covered in this report is segmented –
1) By Type: Drugs, Vaccines
2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases
3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users
Subsegments:
1) By Drugs - Antibiotics, Antivirals, Antifungals, Antiparasitics, Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)
2) By Vaccines - Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Mrna Vaccines, Dna Vaccines, Toxoid Vaccines
Pre-Book The Infectious Disease Therapeutics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Infectious Disease Therapeutics Market?
Key players in the infectious disease therapeutics market are pouring resources into the development of infectious disease drugs in an attempt to devise more potent treatments, tackle antimicrobial resistance, broaden their range of products, and respond to rising infectious hazards. These financial contributions are designed to enhance patient results, fulfil unmet healthcare requirements, and aid worldwide public health initiatives in controlling and managing infectious diseases. For example, GSK, a healthcare company established in the UK, committed £1 billion ($1.09 billion) in June 2022 towards actively dealing with infectious diseases prevalent in low-income nations. This plan is set to bolster research and development activities geared towards fighting diseases that overly impact these areas. The noticeable imbalance in funding and resources for health research between wealthier and low- to middle-income countries underlines the pressing need for such anticipatory investments to promote equal health improvements across populations.
Who Are the Key Players In The Infectious Disease Therapeutics Market?
Major companies operating in the infectious disease therapeutics market are:
• Pfizer Inc.
• Roche Diagnostics Corporation
• F. Hoffmann-La Roche AG
• Merck & Co. Inc.
• Sanofi SA
• Thermo Fisher Scientific
• AstraZeneca
• Abbott Laboratories
• Novartis International AG
• Danaher Corporation
• GlaxoSmithKline plc
• Gilead Sciences Inc.
• Janssen Pharmaceutical
• Siemens Healthineers
• Moderna Inc.
• Becton
• Dickinson
• and Company
• Regeneron Pharmaceuticals Inc.
• Boehringer Ingelheim GmbH
• BioMérieux SA
• Sysmex Corporation
• Bio-Rad Laboratories
• Qiagen N.V.
• Ortho Clinical Diagnostics
• BioCryst Pharmaceuticals Inc.
What Are The Regional Insights Into The Infectious Disease Therapeutics Market?
North America was the largest region in the infectious disease therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
